collagenase
Phase 2Protein / enzyme
collagenase is one of 22 small molecule programs targeting Frozen Shoulder. It is currently in Phase 2.
1
Indications
15
Total Trials
0
Active Trials
21
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
35 competitors in Frozen Shoulder
#DrugCompanyPhaseTrials
1Medrol
PfizerApproved
Elavil
AstraZenecaApproved
Decadron
AAspen Global Incorporated
Approved
Aspercreme Warming
AAveritas Pharma, Inc.
Approved
Rayos
RRoxane Laboratories
Approved
Deltasone
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Xylocaine
MMEDRx USA, Inc.
Approved
Compound Betamethasone
SSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Approved
Kenalog
BBausch Health Americas, Inc.
Phase 3
AMPHADASE
AAmphastar Pharmaceuticals, Inc.
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Dupuytren's Disease2 trials
Treatment2 trials
Pressure Ulcers2 trials
6 more indications
Cutaneous Ulcer1 trial
Negative Pressure Wound Therapy1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for collagenase. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Protein / enzyme[2]
- Highest Phase
- Phase 2[1]
- Company
- MMatrizyme Pharma Corporation